Perhaps the juiciest gossip right now relates to a potential acquisition of Amarin (NASDAQ:AMRN) by Pfizer (NYSE:PFE). Nine days ago, StreetInsider.com reported that Pfizer could be looking to buy Amarin.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,